Literature DB >> 19969066

Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer.

Jorge Sastre-Serra1, Adamo Valle, Maria Margarita Company, Isabel Garau, Jordi Oliver, Pilar Roca.   

Abstract

Oxidative stress has been postulated as one of the mechanisms underlying the estrogen carcinogenic effect in breast cancer. Estrogens are known to increase mitochondrial-derived reactive oxygen species (ROS) by an unknown mechanism. Given that uncoupling proteins (UCPs) are key regulators of mitochondrial energy efficiency and ROS production, our aim was to check the presence and activity of UCPs in estrogen receptor (ER)-positive and ER-negative breast cancer cells and tumors, as well as their relation to oxidative stress. Estrogen (1 nM) induced higher oxidative stress in the ER-positive MCF-7 cell line, showing increased mitochondrial membrane potential, H(2)O(2) levels, and DNA and protein damage compared to ER-negative MDA-MB-231 cells. All isoforms of uncoupling proteins were highly expressed in ER-positive breast cancer cells and tumors compared to negative ones. ROS production in mitochondria isolated from MCF-7 was increased by inhibition of UCPs with GDP, but not in mitochondria from MDA-MB-231. Estrogen treatment decreased uncoupling protein and catalase levels in MCF-7 and decreased GDP-dependent ROS production in isolated mitochondria. On the whole, these results suggest that estrogens, through an ER-dependent mechanism, may increase mitochondrial ROS production by repressing uncoupling proteins, which offers a new perspective on the understanding of why estrogens are a risk factor for breast cancer. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19969066     DOI: 10.1016/j.freeradbiomed.2009.11.025

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  30 in total

Review 1.  Redox metabolism and malignancy.

Authors:  Christina L Grek; Kenneth D Tew
Journal:  Curr Opin Pharmacol       Date:  2010-06-04       Impact factor: 5.547

Review 2.  UCP2, a mitochondrial protein regulated at multiple levels.

Authors:  Massimo Donadelli; Ilaria Dando; Claudia Fiorini; Marta Palmieri
Journal:  Cell Mol Life Sci       Date:  2013-06-27       Impact factor: 9.261

Review 3.  Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review.

Authors:  Nazanin Momeni Roudsari; Naser-Aldin Lashgari; Saeideh Momtaz; Mohammad Hosein Farzaei; André M Marques; Amir Hossein Abdolghaffari
Journal:  Daru       Date:  2019-07-04       Impact factor: 3.117

Review 4.  Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy.

Authors:  Massimo Donadelli; Ilaria Dando; Elisa Dalla Pozza; Marta Palmieri
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

5.  Estrogen Drives Cellular Transformation and Mutagenesis in Cells Expressing the Breast Cancer-Associated R438W DNA Polymerase Lambda Protein.

Authors:  Antonia A Nemec; Korie B Bush; Jamie B Towle-Weicksel; B Frazier Taylor; Vincent Schulz; Joanne B Weidhaas; David P Tuck; Joann B Sweasy
Journal:  Mol Cancer Res       Date:  2016-09-12       Impact factor: 5.852

6.  Estrogen receptor beta interacts and colocalizes with HADHB in mitochondria.

Authors:  Zhenqi Zhou; Jianhong Zhou; Yuchun Du
Journal:  Biochem Biophys Res Commun       Date:  2012-09-18       Impact factor: 3.575

Review 7.  Linking DNA Damage and Hormone Signaling Pathways in Cancer.

Authors:  Matthew J Schiewer; Karen E Knudsen
Journal:  Trends Endocrinol Metab       Date:  2016-03-01       Impact factor: 12.015

Review 8.  Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement.

Authors:  Molly M Morgan; Brian P Johnson; Megan K Livingston; Linda A Schuler; Elaine T Alarid; Kyung E Sung; David J Beebe
Journal:  Pharmacol Ther       Date:  2016-05-21       Impact factor: 12.310

9.  Prognostic Value of Peroxiredoxin-1 Expression in Patients with Solid Tumors: a Meta-Analysis of Cohort Study.

Authors:  Lianghe Jiao; Jing Wei; Jun Ye; Chuanmeng Zhang
Journal:  Dis Markers       Date:  2021-03-03       Impact factor: 3.434

10.  Human neuronal uncoupling proteins 4 and 5 (UCP4 and UCP5): structural properties, regulation, and physiological role in protection against oxidative stress and mitochondrial dysfunction.

Authors:  David B Ramsden; Philip W-L Ho; Jessica W-M Ho; Hui-Fang Liu; Danny H-F So; Ho-Man Tse; Koon-Ho Chan; Shu-Leong Ho
Journal:  Brain Behav       Date:  2012-07       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.